Summary

The global Pharmacovigilance Solutions market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026?2032.
North America: the Pharmacovigilance Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026?2032. Europe: the Pharmacovigilance Solutions market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026?2032. Asia Pacific: the Pharmacovigilance Solutions market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026?2032. Leading global service providers of Pharmacovigilance Solutions include Eurofins Scientific, Accenture, PPD, SGS, WuXi AppTec, Cognizant, ICON, IQVIA and Parexel, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharmacovigilance Solutions market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021?2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmacovigilance Solutions.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021?2025 results and a 2026?2032 outlook?covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and?where applicable?volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmacovigilance Solutions Market by Company
Eurofins Scientific
Accenture
PPD
SGS
WuXi AppTec
Cognizant
ICON
IQVIA
Parexel
United BioSource
Vial
Wipro
PrimeVigilance
Aixial Group
TransPerfect
ProPharma
HCLTech
QbD Group
Quanticate
Qinecsa Solutions
Veristat
Veeda
Tigermed
Clarivate

Pharmacovigilance Solutions Segment by Type
Writing and Submitting Documents and Reports
Security Database System Services and Data Management
Signal Detection and Evaluation
Training and Consulting
Other

Pharmacovigilance Solutions Segment by Application
Preclinical
Clinical Phase
Post-launch

Pharmacovigilance Solutions Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt


Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance Solutions.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmacovigilance Solutions companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

ページTOPに戻る

Table of Contents

1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources

2 Market Overview
2.1 Product Definition
2.2 Pharmacovigilance Solutions by Type
2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
2.2.2 Writing and Submitting Documents and Reports
2.2.3 Security Database System Services and Data Management
2.2.4 Signal Detection and Evaluation
2.2.5 Training and Consulting
2.2.6 Other
2.3 Pharmacovigilance Solutions by Application
2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.3.2 Preclinical
2.3.3 Clinical Phase
2.3.4 Post-launch
2.4 Assumptions and Limitations

3 Pharmacovigilance Solutions Breakdown Data by Type
3.1 Global Pharmacovigilance Solutions Historic Market Size by Type (2021-2026)
3.2 Global Pharmacovigilance Solutions Forecasted Market Size by Type (2027-2032)

4 Pharmacovigilance Solutions Breakdown Data by Application
4.1 Global Pharmacovigilance Solutions Historic Market Size by Application (2021-2026)
4.2 Global Pharmacovigilance Solutions Forecasted Market Size by Application (2027-2032)

5 Global Growth Trends
5.1 Global Pharmacovigilance Solutions Market Perspective (2021-2032)
5.2 Global Pharmacovigilance Solutions Growth Trends by Region
5.2.1 Global Pharmacovigilance Solutions Market Size by Region: 2021 VS 2025 VS 2032
5.2.2 Pharmacovigilance Solutions Historic Market Size by Region (2021-2026)
5.2.3 Pharmacovigilance Solutions Forecasted Market Size by Region (2027-2032)
5.3 Pharmacovigilance Solutions Market Dynamics
5.3.1 Pharmacovigilance Solutions Industry Trends
5.3.2 Pharmacovigilance Solutions Market Drivers
5.3.3 Pharmacovigilance Solutions Market Challenges
5.3.4 Pharmacovigilance Solutions Market Restraints

6 Market Competitive Landscape by Players
6.1 Global Top Pharmacovigilance Solutions Players by Revenue
6.1.1 Global Top Pharmacovigilance Solutions Players by Revenue (2021-2026)
6.1.2 Global Pharmacovigilance Solutions Revenue Market Share by Players (2021-2026)
6.2 Global Pharmacovigilance Solutions Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Pharmacovigilance Solutions Head Office and Area Served
6.4 Global Pharmacovigilance Solutions Players, Product Type & Application
6.5 Global Pharmacovigilance Solutions Manufacturers Established Date
6.6 Global Pharmacovigilance Solutions Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 North America
7.1 North America Pharmacovigilance Solutions Market Size (2021-2032)
7.2 North America Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
7.3 North America Pharmacovigilance Solutions Market Size by Country (2021-2026)
7.4 North America Pharmacovigilance Solutions Market Size by Country (2027-2032)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico

8 Europe
8.1 Europe Pharmacovigilance Solutions Market Size (2021-2032)
8.2 Europe Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
8.3 Europe Pharmacovigilance Solutions Market Size by Country (2021-2026)
8.4 Europe Pharmacovigilance Solutions Market Size by Country (2027-2032)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries

9 Asia-Pacific
9.1 Asia-Pacific Pharmacovigilance Solutions Market Size (2021-2032)
9.2 Asia-Pacific Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
9.3 Asia-Pacific Pharmacovigilance Solutions Market Size by Country (2021-2026)
9.4 Asia-Pacific Pharmacovigilance Solutions Market Size by Country (2027-2032)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia

10 South America
10.1 South America Pharmacovigilance Solutions Market Size (2021-2032)
10.2 South America Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
10.3 South America Pharmacovigilance Solutions Market Size by Country (2021-2026)
10.4 South America Pharmacovigilance Solutions Market Size by Country (2027-2032)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru

11 Middle East & Africa
11.1 Middle East & Africa Pharmacovigilance Solutions Market Size (2021-2032)
11.2 Middle East & Africa Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032
11.3 Middle East & Africa Pharmacovigilance Solutions Market Size by Country (2021-2026)
11.4 Middle East & Africa Pharmacovigilance Solutions Market Size by Country (2027-2032)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt

12 Players Profiled
12.1 Eurofins Scientific
12.1.1 Eurofins Scientific Company Information
12.1.2 Eurofins Scientific Business Overview
12.1.3 Eurofins Scientific Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.1.4 Eurofins Scientific Pharmacovigilance Solutions Product Portfolio
12.1.5 Eurofins Scientific Recent Developments
12.2 Accenture
12.2.1 Accenture Company Information
12.2.2 Accenture Business Overview
12.2.3 Accenture Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.2.4 Accenture Pharmacovigilance Solutions Product Portfolio
12.2.5 Accenture Recent Developments
12.3 PPD
12.3.1 PPD Company Information
12.3.2 PPD Business Overview
12.3.3 PPD Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.3.4 PPD Pharmacovigilance Solutions Product Portfolio
12.3.5 PPD Recent Developments
12.4 SGS
12.4.1 SGS Company Information
12.4.2 SGS Business Overview
12.4.3 SGS Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.4.4 SGS Pharmacovigilance Solutions Product Portfolio
12.4.5 SGS Recent Developments
12.5 WuXi AppTec
12.5.1 WuXi AppTec Company Information
12.5.2 WuXi AppTec Business Overview
12.5.3 WuXi AppTec Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.5.4 WuXi AppTec Pharmacovigilance Solutions Product Portfolio
12.5.5 WuXi AppTec Recent Developments
12.6 Cognizant
12.6.1 Cognizant Company Information
12.6.2 Cognizant Business Overview
12.6.3 Cognizant Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.6.4 Cognizant Pharmacovigilance Solutions Product Portfolio
12.6.5 Cognizant Recent Developments
12.7 ICON
12.7.1 ICON Company Information
12.7.2 ICON Business Overview
12.7.3 ICON Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.7.4 ICON Pharmacovigilance Solutions Product Portfolio
12.7.5 ICON Recent Developments
12.8 IQVIA
12.8.1 IQVIA Company Information
12.8.2 IQVIA Business Overview
12.8.3 IQVIA Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.8.4 IQVIA Pharmacovigilance Solutions Product Portfolio
12.8.5 IQVIA Recent Developments
12.9 Parexel
12.9.1 Parexel Company Information
12.9.2 Parexel Business Overview
12.9.3 Parexel Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.9.4 Parexel Pharmacovigilance Solutions Product Portfolio
12.9.5 Parexel Recent Developments
12.10 United BioSource
12.10.1 United BioSource Company Information
12.10.2 United BioSource Business Overview
12.10.3 United BioSource Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.10.4 United BioSource Pharmacovigilance Solutions Product Portfolio
12.10.5 United BioSource Recent Developments
12.11 Vial
12.11.1 Vial Company Information
12.11.2 Vial Business Overview
12.11.3 Vial Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.11.4 Vial Pharmacovigilance Solutions Product Portfolio
12.11.5 Vial Recent Developments
12.12 Wipro
12.12.1 Wipro Company Information
12.12.2 Wipro Business Overview
12.12.3 Wipro Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.12.4 Wipro Pharmacovigilance Solutions Product Portfolio
12.12.5 Wipro Recent Developments
12.13 PrimeVigilance
12.13.1 PrimeVigilance Company Information
12.13.2 PrimeVigilance Business Overview
12.13.3 PrimeVigilance Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.13.4 PrimeVigilance Pharmacovigilance Solutions Product Portfolio
12.13.5 PrimeVigilance Recent Developments
12.14 Aixial Group
12.14.1 Aixial Group Company Information
12.14.2 Aixial Group Business Overview
12.14.3 Aixial Group Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.14.4 Aixial Group Pharmacovigilance Solutions Product Portfolio
12.14.5 Aixial Group Recent Developments
12.15 TransPerfect
12.15.1 TransPerfect Company Information
12.15.2 TransPerfect Business Overview
12.15.3 TransPerfect Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.15.4 TransPerfect Pharmacovigilance Solutions Product Portfolio
12.15.5 TransPerfect Recent Developments
12.16 ProPharma
12.16.1 ProPharma Company Information
12.16.2 ProPharma Business Overview
12.16.3 ProPharma Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.16.4 ProPharma Pharmacovigilance Solutions Product Portfolio
12.16.5 ProPharma Recent Developments
12.17 HCLTech
12.17.1 HCLTech Company Information
12.17.2 HCLTech Business Overview
12.17.3 HCLTech Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.17.4 HCLTech Pharmacovigilance Solutions Product Portfolio
12.17.5 HCLTech Recent Developments
12.18 QbD Group
12.18.1 QbD Group Company Information
12.18.2 QbD Group Business Overview
12.18.3 QbD Group Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.18.4 QbD Group Pharmacovigilance Solutions Product Portfolio
12.18.5 QbD Group Recent Developments
12.19 Quanticate
12.19.1 Quanticate Company Information
12.19.2 Quanticate Business Overview
12.19.3 Quanticate Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.19.4 Quanticate Pharmacovigilance Solutions Product Portfolio
12.19.5 Quanticate Recent Developments
12.20 Qinecsa Solutions
12.20.1 Qinecsa Solutions Company Information
12.20.2 Qinecsa Solutions Business Overview
12.20.3 Qinecsa Solutions Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.20.4 Qinecsa Solutions Pharmacovigilance Solutions Product Portfolio
12.20.5 Qinecsa Solutions Recent Developments
12.21 Veristat
12.21.1 Veristat Company Information
12.21.2 Veristat Business Overview
12.21.3 Veristat Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.21.4 Veristat Pharmacovigilance Solutions Product Portfolio
12.21.5 Veristat Recent Developments
12.22 Veeda
12.22.1 Veeda Company Information
12.22.2 Veeda Business Overview
12.22.3 Veeda Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.22.4 Veeda Pharmacovigilance Solutions Product Portfolio
12.22.5 Veeda Recent Developments
12.23 Tigermed
12.23.1 Tigermed Company Information
12.23.2 Tigermed Business Overview
12.23.3 Tigermed Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.23.4 Tigermed Pharmacovigilance Solutions Product Portfolio
12.23.5 Tigermed Recent Developments
12.24 Clarivate
12.24.1 Clarivate Company Information
12.24.2 Clarivate Business Overview
12.24.3 Clarivate Revenue in Pharmacovigilance Solutions Business (2021-2026)
12.24.4 Clarivate Pharmacovigilance Solutions Product Portfolio
12.24.5 Clarivate Recent Developments

13 Report Conclusion
14 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Pharmacovigilance Solutions Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Pharmacovigilance Solutions Revenue Market Share by Type (2021-2026)
Table 7. Global Pharmacovigilance Solutions Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Pharmacovigilance Solutions Revenue Market Share by Type (2027-2032)
Table 9. Global Pharmacovigilance Solutions Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Pharmacovigilance Solutions Revenue Market Share by Application (2021-2026)
Table 11. Global Pharmacovigilance Solutions Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Pharmacovigilance Solutions Revenue Market Share by Application (2027-2032)
Table 13. Global Pharmacovigilance Solutions Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Pharmacovigilance Solutions Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Pharmacovigilance Solutions Market Share by Region (2021-2026)
Table 16. Global Pharmacovigilance Solutions Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Pharmacovigilance Solutions Market Share by Region (2027-2032)
Table 18. Pharmacovigilance Solutions Industry Trends
Table 19. Pharmacovigilance Solutions Industry Drivers
Table 20. Pharmacovigilance Solutions Industry Opportunities and Challenges
Table 21. Pharmacovigilance Solutions Market Restraints
Table 22. Global Top Pharmacovigilance Solutions Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Pharmacovigilance Solutions Revenue Market Share by Players (2021-2026)
Table 24. Global Pharmacovigilance Solutions Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Pharmacovigilance Solutions, Headquarters and Area Served
Table 26. Global Pharmacovigilance Solutions Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Pharmacovigilance Solutions by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Pharmacovigilance Solutions Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Pharmacovigilance Solutions Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Pharmacovigilance Solutions Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Pharmacovigilance Solutions Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Pharmacovigilance Solutions Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Pharmacovigilance Solutions Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Pharmacovigilance Solutions Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Pharmacovigilance Solutions Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Pharmacovigilance Solutions Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Pharmacovigilance Solutions Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Pharmacovigilance Solutions Market Size by Country (2027-2032) & (US$ Million)
Table 45. Eurofins Scientific Company Information
Table 46. Eurofins Scientific Business Overview
Table 47. Eurofins Scientific Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 48. Eurofins Scientific Pharmacovigilance Solutions Product Portfolio
Table 49. Eurofins Scientific Recent Developments
Table 50. Accenture Company Information
Table 51. Accenture Business Overview
Table 52. Accenture Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 53. Accenture Pharmacovigilance Solutions Product Portfolio
Table 54. Accenture Recent Developments
Table 55. PPD Company Information
Table 56. PPD Business Overview
Table 57. PPD Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 58. PPD Pharmacovigilance Solutions Product Portfolio
Table 59. PPD Recent Developments
Table 60. SGS Company Information
Table 61. SGS Business Overview
Table 62. SGS Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 63. SGS Pharmacovigilance Solutions Product Portfolio
Table 64. SGS Recent Developments
Table 65. WuXi AppTec Company Information
Table 66. WuXi AppTec Business Overview
Table 67. WuXi AppTec Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 68. WuXi AppTec Pharmacovigilance Solutions Product Portfolio
Table 69. WuXi AppTec Recent Developments
Table 70. Cognizant Company Information
Table 71. Cognizant Business Overview
Table 72. Cognizant Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 73. Cognizant Pharmacovigilance Solutions Product Portfolio
Table 74. Cognizant Recent Developments
Table 75. ICON Company Information
Table 76. ICON Business Overview
Table 77. ICON Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 78. ICON Pharmacovigilance Solutions Product Portfolio
Table 79. ICON Recent Developments
Table 80. IQVIA Company Information
Table 81. IQVIA Business Overview
Table 82. IQVIA Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 83. IQVIA Pharmacovigilance Solutions Product Portfolio
Table 84. IQVIA Recent Developments
Table 85. Parexel Company Information
Table 86. Parexel Business Overview
Table 87. Parexel Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 88. Parexel Pharmacovigilance Solutions Product Portfolio
Table 89. Parexel Recent Developments
Table 90. United BioSource Company Information
Table 91. United BioSource Business Overview
Table 92. United BioSource Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 93. United BioSource Pharmacovigilance Solutions Product Portfolio
Table 94. United BioSource Recent Developments
Table 95. Vial Company Information
Table 96. Vial Business Overview
Table 97. Vial Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 98. Vial Pharmacovigilance Solutions Product Portfolio
Table 99. Vial Recent Developments
Table 100. Wipro Company Information
Table 101. Wipro Business Overview
Table 102. Wipro Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 103. Wipro Pharmacovigilance Solutions Product Portfolio
Table 104. Wipro Recent Developments
Table 105. PrimeVigilance Company Information
Table 106. PrimeVigilance Business Overview
Table 107. PrimeVigilance Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 108. PrimeVigilance Pharmacovigilance Solutions Product Portfolio
Table 109. PrimeVigilance Recent Developments
Table 110. Aixial Group Company Information
Table 111. Aixial Group Business Overview
Table 112. Aixial Group Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 113. Aixial Group Pharmacovigilance Solutions Product Portfolio
Table 114. Aixial Group Recent Developments
Table 115. TransPerfect Company Information
Table 116. TransPerfect Business Overview
Table 117. TransPerfect Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 118. TransPerfect Pharmacovigilance Solutions Product Portfolio
Table 119. TransPerfect Recent Developments
Table 120. ProPharma Company Information
Table 121. ProPharma Business Overview
Table 122. ProPharma Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 123. ProPharma Pharmacovigilance Solutions Product Portfolio
Table 124. ProPharma Recent Developments
Table 125. HCLTech Company Information
Table 126. HCLTech Business Overview
Table 127. HCLTech Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 128. HCLTech Pharmacovigilance Solutions Product Portfolio
Table 129. HCLTech Recent Developments
Table 130. QbD Group Company Information
Table 131. QbD Group Business Overview
Table 132. QbD Group Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 133. QbD Group Pharmacovigilance Solutions Product Portfolio
Table 134. QbD Group Recent Developments
Table 135. Quanticate Company Information
Table 136. Quanticate Business Overview
Table 137. Quanticate Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 138. Quanticate Pharmacovigilance Solutions Product Portfolio
Table 139. Quanticate Recent Developments
Table 140. Qinecsa Solutions Company Information
Table 141. Qinecsa Solutions Business Overview
Table 142. Qinecsa Solutions Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 143. Qinecsa Solutions Pharmacovigilance Solutions Product Portfolio
Table 144. Qinecsa Solutions Recent Developments
Table 145. Veristat Company Information
Table 146. Veristat Business Overview
Table 147. Veristat Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 148. Veristat Pharmacovigilance Solutions Product Portfolio
Table 149. Veristat Recent Developments
Table 150. Veeda Company Information
Table 151. Veeda Business Overview
Table 152. Veeda Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 153. Veeda Pharmacovigilance Solutions Product Portfolio
Table 154. Veeda Recent Developments
Table 155. Tigermed Company Information
Table 156. Tigermed Business Overview
Table 157. Tigermed Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 158. Tigermed Pharmacovigilance Solutions Product Portfolio
Table 159. Tigermed Recent Developments
Table 160. Clarivate Company Information
Table 161. Clarivate Business Overview
Table 162. Clarivate Revenue in Pharmacovigilance Solutions Business (2021-2026) & (US$ Million)
Table 163. Clarivate Pharmacovigilance Solutions Product Portfolio
Table 164. Clarivate Recent Developments
Table 165. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Pharmacovigilance Solutions Product Image
Figure 5. Global Pharmacovigilance Solutions Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Pharmacovigilance Solutions Market Share by Type: 2025 VS 2032
Figure 7. Writing and Submitting Documents and Reports Product
Figure 8. Security Database System Services and Data Management Product
Figure 9. Signal Detection and Evaluation Product
Figure 10. Training and Consulting Product
Figure 11. Other Product
Figure 12. Global Pharmacovigilance Solutions Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 13. Global Pharmacovigilance Solutions Market Share by Application: 2025 VS 2032
Figure 14. Preclinical Product
Figure 15. Clinical Phase Product
Figure 16. Post-launch Product
Figure 17. Global Pharmacovigilance Solutions Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 18. Global Pharmacovigilance Solutions Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 19. Global Pharmacovigilance Solutions Market Share by Region: 2025 VS 2032
Figure 20. Global Pharmacovigilance Solutions Market Share by Players in 2025
Figure 21. Global Pharmacovigilance Solutions Manufacturers Established Date
Figure 22. Global Top 5 and 10 Pharmacovigilance Solutions Players Market Share by Revenue in 2025
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 24. North America Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. North America Pharmacovigilance Solutions Market Share by Country (2021-2032)
Figure 26. United States Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Canada Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Mexico Pharmacovigilance Solutions Market Share by Country (2021-2032)
Figure 29. Europe Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Europe Pharmacovigilance Solutions Market Share by Country (2021-2032)
Figure 31. Germany Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. France Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. U.K. Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Italy Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Spain Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Russia Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Netherlands Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Nordic Countries Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Asia-Pacific Pharmacovigilance Solutions Market Share by Country (2021-2032)
Figure 41. China Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Japan Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. South Korea Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. India Pharmacovigilance Solutions Market Share by Country (2021-2032)
Figure 46. Australia Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. China Taiwan Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. Southeast Asia Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. South America Pharmacovigilance Solutions Market Share by Country (2021-2032)
Figure 51. Brazil Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Argentina Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Chile Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Colombia Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Peru Pharmacovigilance Solutions Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Eurofins Scientific Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 57. Accenture Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 58. PPD Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 59. SGS Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 60. WuXi AppTec Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 61. Cognizant Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 62. ICON Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 63. IQVIA Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 64. Parexel Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 65. United BioSource Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 66. Vial Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 67. Wipro Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 68. PrimeVigilance Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 69. Aixial Group Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 70. TransPerfect Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 71. ProPharma Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 72. HCLTech Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 73. QbD Group Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 74. Quanticate Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 75. Qinecsa Solutions Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 76. Veristat Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 77. Veeda Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 78. Tigermed Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)
Figure 79. Clarivate Revenue Growth Rate in Pharmacovigilance Solutions Business (2021-2026)